Search for media from: "Bharathi Vennapusa"

NTRK fusions: VENTANA pan-TRK (EPR17341) Assay

Drs. Bharathi Vennapusa, Denise Croix and Katie Robertson discuss overview of NTRK fusions, testing methods, algorithms with a focus on pan-TRK IHC assay using VENTANA pan-TRK (EPR17341) Assay. …

From  Bharathi Vennapusa on January 31st, 2021 1 likes 9 plays

Down the Ocular Episode-1-NTRK overview, testing methods and algorithms and pan-TRK IHC assay

Down the Ocular Episode # 2: VENTANA pan-TRK (EPR17341) Assay: This episode focuses on the NTRK fusions; their detection, the testing methodologies used, and their role in solid tumors. Dr. Bharathi…

From  Bharathi Vennapusa on October 10th, 2020 0 likes 25 plays

VENTANA HER2 Dual ISH DNA Probe Cocktail – Review of Scoring Algorithm

Brief video on scoring algorithm for VENTANA HER2 Dual ISH DNA Probe Cocktail. Content and approvals of any product related information is current as of the date of publishing.

From  Bharathi Vennapusa on November 19th, 2020 0 likes 0 plays

Down the Ocular episode 4 - CAP_ASCO 2018 guidelines and Roche HER2 assays

This is episode 4 of the Down the Ocular podcast. In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the 2018…

From  Bharathi Vennapusa on November 19th, 2020 0 likes 5 plays

Down the Ocular Pilot Episode - Remote Digital Pathology Devices - Guidance during COVID-19 Pandemic

In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the use of digital pathology devices during the COVID-19…

From  Bharathi Vennapusa on November 20th, 2020 0 likes 2 plays

Down the Ocular Episode # 2 - VENTANA PD-L1 (SP142) Assay in NSCLC Part 1

In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the PD-L1 (SP142) assay in non-small cell lung cancer. Drs.…

From  Bharathi Vennapusa on November 20th, 2020 0 likes 4 plays

Down the Ocular Episode # 3 - VENTANA PD-L1 (SP142) Assay in NSCLC Part 2

This episode is part 2 in a series on the PD-L1 (SP142) assay in non small cell lung cancer. In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD…

From  Bharathi Vennapusa on November 20th, 2020 0 likes 2 plays

Pan-TRK IHC with VENTANA pan-TRK (EPR17341) Assay

Dr. Bharathi Vennapusa from Roche MSA discusses Pan-TRK IHC using VENTANA pan-TRK (EPR17341) Assay. Content and approvals of any product related info is current as of the date of publishing. …

From  Bharathi Vennapusa on November 20th, 2020 0 likes 14 plays

CAP/ASCO HER2 2018 Guideline update and RocheHER2 Assays

Dr. Bharathi Vennapusa from Roche MSA discusses 2018 CAP/ASCO HER2 guideline update and how it pertains to Roche HER2 Assays. Content and approvals of any product related information is current as of…

From  Bharathi Vennapusa on November 20th, 2020 0 likes 7 plays

NTRK fusions: Biology and Testing Methods

Dr. Denise Croix from Roche MSA discusses NTRK fusions biology and testing methods. Content and approvals of any product related info is current as of the date of publishing. TE-US-00861

From  Bharathi Vennapusa on November 20th, 2020 0 likes 23 plays

Interpretation of VENTANA pan-TRK (EPR17341) Assay - digital case review

Dr. Bharathi Vennapusa from Roche MSA reviews example cases stained with VENTANA pan-TRK (EPR17341) Assay using digital slides. Content and approvals of any product related info is current as of the…

From  Bharathi Vennapusa on November 20th, 2020 0 likes 16 plays

NTRK fusions: Testing Algorithms

Dr. Katie Robertson from Roche MSA discusses testing algorithms for NTRK fusion testing. Content and approvals of any product related info is current as of the date of publishing. …

From  Bharathi Vennapusa on November 20th, 2020 0 likes 20 plays

Tumor Microenvironment and PD-L1 biomarker

US Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses the tumor microenvironment, the cancer immunity cycle, the immune…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 6 plays

PD-L1 Expression on Immune and Tumor Cells

US Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses: 1. How and why PD-L1 is present on tumor cells as well as being…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 12 plays

PD-L1 Testing and Developmental Process for Companion Diagnostic Tests

US Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses on: 1. The PD-L1 biomarker and its role in immunotherapy - time…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 13 plays

PD-L1 Testing and SP142 IHC Assay as a Diagnostic Tool in Urothelial Carcinoma

US Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses: 1. SP142 assay is optimized for staining for both immune and…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 9 plays